SARCOIDOSIS, PULMONARY
Clinical trials for SARCOIDOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowThis study tests whether hydroxychloroquine, a drug used for malaria and autoimmune diseases, can help people with sarcoidosis use less steroids while still controlling their disease. About 140 adults with sarcoidosis affecting areas outside the lungs (like skin, eyes, or bones) …
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Could a diabetes drug help lung patients lose weight safely?
Symptom relief Recruiting nowThis small pilot study is testing whether semaglutide, a drug already approved for diabetes and obesity, is safe and tolerable for people with advanced lung diseases like COPD or pulmonary fibrosis. Eight participants will take the drug for 12 weeks while researchers monitor side…
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE1, PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
New study aims to predict lung outcomes in sarcoidosis patients
Knowledge-focused Recruiting nowThis study is for adults with sarcoidosis, a disease that can affect the lungs. Researchers want to create models that predict how the lungs will change over time using simple blood tests and clinic data. The goal is to help doctors better understand and manage the disease. About…
Matched conditions: SARCOIDOSIS, PULMONARY
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 17, 2026 05:06 UTC